Skip to main content

Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to November 2026.

37,497
Total recall recordsAll FDA and USDA recalls in Public Health Trace
9,881
Class I recallsReasonable probability of serious health consequences
24,543
Class II recallsTemporary or medically reversible health consequences
2,935
Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls
Most common hazardLack of Assurance of Sterility 2,098 recalls
Most affected stateHawaii 200 recalls mention this state

Advertisement

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters
Recall details
Location
Date range
Sort results
Clear filters
Metric
View
Recalls announced by month (Year to date)

A chart of recalls grouped by month.

Download CSV

Source: FDA and USDA public dataLast updated

Summary (Year to date)

  • 1,956 recalls have been announced year to date.
  • Oct 2026 was 4% higher than the previous complete period (Sep 2026: 209).
  • The highest complete period was Jun 2026 (300).
  • Nov 2026 is incomplete and not included in the figures above.
  • Complete data
  • Incomplete
Recalls by class

A bar chart of the total number of recalls in this dataset by recall class.

Recalls by class
ClassRecalls
Class II24,543
Class I9,881
Class III2,935
Not Yet Classified2
Download CSV
Recalls by class
ClassRecalls
Class II24,543
Class I9,881
Class III2,935
Not Yet Classified2

Showing 17,881–17,900 of 21,347 recalls

FDA Recall TerminatedTerminated: April 19, 2017Historical recordClass II

Refresh Lacri-Lube (Mineral Oil 42.5% and White Petrolatum 56.8%) Lubricant Eye Ointment, packaged in a) Net wt. 0.12 oz (3.5 g) tubes (NDC 0023-0312-04) UPC 3 0023-0312-04 2 and b) Net wt. 0.25 oz (7 g) tubes (NDC 0023-0312-07) UPC 3 0023-0312-07 3, Allergan, Inc., 2525 Dupont Drive, Irvine, CA 92612.

by Allergan Sales, LLC

Reason
Presence of Particulate Matter: Due to customer complaints of small black particles, identified as part of the ointment tube cap, generated by the action of unscrewing the cap from the aluminum tube and potentially introducing the particle into the product.
Published
September 30, 2015
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: September 15, 2016Historical recordClass II

0.9% Sodium Chloride Injection, USP, 100 mL MINI-BAG VIAFLEX Container, Single Dose Container, Rx Only, Baxter Healthcare Corporation, Deerfield, IL 60015, USA, NDC 0338-0049-38

by Baxter Healthcare Corporation

Reason
Lack of Assurance of Sterility: Recalling firm reported a complaint for mold on the interior surface of the overpouch.
Published
September 30, 2015
Distribution
Nationwide

View recall →

FDA Recall OngoingHistorical recordClass II

1% Lidocaine HCl Injection, USP, 10 mg/mL, 30 mL Vial, Single-dose Preservative Free, Rx only, Hospira, Inc., Lake Forest, IL 60045, USA, NDC 0409-4279-02

by Hospira, Inc.

Reason
Presence of Particulate Matter: particulate matter identified as iron oxide, was found embedded in the neck of glass vials.
Published
September 30, 2015
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: February 10, 2016Historical recordClass II

Tri-Mix T-50/PGE 2/LIDO 2 0.09/0.32/0.04 Injectable, The Compounding Pharmacy of America, Knoxville, TN

by The Compounding Pharmacy of America

Reason
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
Published
September 23, 2015
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: February 10, 2016Historical recordClass II

Tri-Mix T-50/PGE 2/LIDO 2 0.03/0.18/0.09 Injectable, The Compounding Pharmacy of America, Knoxville, TN

by The Compounding Pharmacy of America

Reason
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
Published
September 23, 2015
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: February 10, 2016Historical recordClass II

Tri-Mix T-106 (30 mg/1 mg/25 mcg) Injectable,The Compounding Pharmacy of America, Knoxville, TN

by The Compounding Pharmacy of America

Reason
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
Published
September 23, 2015
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: February 10, 2016Historical recordClass II

Tri-Mix T-102/PGE 2/LIDO 2 0.06/0.3/0.2 Injectable, The Compounding Pharmacy of America, Knoxville, TN

by The Compounding Pharmacy of America

Reason
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
Published
September 23, 2015
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: February 10, 2016Historical recordClass II

Tri-Mix T-101 (17.65 mg/0.59 mg/5.9 mcg) Injectable, The Compounding Pharmacy of America, Knoxville, TN

by The Compounding Pharmacy of America

Reason
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
Published
September 23, 2015
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: February 10, 2016Historical recordClass II

Tri-Mix SUPER (28 mg/0.9 mg/37 mcg) Injectable, Sterile Keep Frozen, The Compounding Pharmacy of America, Knoxville, TN

by The Compounding Pharmacy of America

Reason
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
Published
September 23, 2015
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: February 10, 2016Historical recordClass II

Tri-Mix ST9E (60 mg/4 mg/150 mcg) Injectable, Sterile Keep Frozen, The Compounding Pharmacy of America, Knoxville, TN

by The Compounding Pharmacy of America

Reason
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
Published
September 23, 2015
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: February 10, 2016Historical recordClass II

Tri-Mix ST9C (30 mg/2 mg/120 mcg) Injectable, The Compounding Pharmacy of America, Knoxville, TN

by The Compounding Pharmacy of America

Reason
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
Published
September 23, 2015
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: February 10, 2016Historical recordClass II

Tri-Mix ST9A (30 mg/2 mg/80 mcg) Injectable, The Compounding Pharmacy of America, Knoxville, TN

by The Compounding Pharmacy of America

Reason
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
Published
September 23, 2015
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: February 10, 2016Historical recordClass II

Tri-Mix ST2 (30 mg/3 mg/100 mcg) Injectable, The Compounding Pharmacy of America, Knoxville, TN

by The Compounding Pharmacy of America

Reason
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
Published
September 23, 2015
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: February 10, 2016Historical recordClass II

Tri-Mix ST1 (30 mg/1.5 mg/50 mcg) Injectable, The Compounding Pharmacy of America, Knoxville, TN

by The Compounding Pharmacy of America

Reason
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
Published
September 23, 2015
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: February 10, 2016Historical recordClass II

Tri-Mix MEDIUM (15/0.5/5) (MFG) Injectable, The Compounding Pharmacy of America, Knoxville, TN

by The Compounding Pharmacy of America

Reason
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
Published
September 23, 2015
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: February 10, 2016Historical recordClass II

Tri-Mix (30/2/20) (MFG) Injectable, The Compounding Pharmacy of America, Knoxville, TN

by The Compounding Pharmacy of America

Reason
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
Published
September 23, 2015
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: February 10, 2016Historical recordClass II

Tri-Mix (30/2/20) Injectable, The Compounding Pharmacy of America, Knoxville, TN

by The Compounding Pharmacy of America

Reason
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
Published
September 23, 2015
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: February 10, 2016Historical recordClass II

Tri-Mix (30/1/22) Injectable, The Compounding Pharmacy of America, Knoxville, TN

by The Compounding Pharmacy of America

Reason
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
Published
September 23, 2015
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: February 10, 2016Historical recordClass II

Tri-Mix (30/1/10) (MFG) Injectable, The Compounding Pharmacy of America, Knoxville, TN

by The Compounding Pharmacy of America

Reason
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
Published
September 23, 2015
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: February 10, 2016Historical recordClass II

Tri-Mix (30/1/10) Injectable, The Compounding Pharmacy of America, Knoxville, TN

by The Compounding Pharmacy of America

Reason
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
Published
September 23, 2015
Distribution
Nationwide

View recall →

Data last updated:

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.

Reconnecting to the server…

We lost the connection to the server.

Your session has expired.